AHA 2018: The latest updates on CVOT data for Type 2 DM therapies - Prof Carolyn Lam & Prof John McMurray

 

Prof Carolyn Lam (National Heart Center, SG) & Prof John McMurray (University of Glasgow, UK) discuss the latest updates on CVOT data for Type 2 DM therapies.

 

Filmed by Radcliffe Cardiology on site at AHA 2018.

 

This peer-to-peer discussion was funded by an unrestricted grant by Novo Nordisk. 

Video Category: 

  • Diabetes